Clin2
NCT07484217Possibly a fitRecruiting

Testing solriamfetol for depression with daytime sleepiness

Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This study tests if the drug solriamfetol can help people with major depression who also feel very tired during the day. It aims to improve both mood and daytime sleepiness.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
508 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must have a diagnosis of major depression without psychosis.
  • You must feel very sleepy or drowsy during the day (excessive daytime sleepiness).
  • You must be willing and able to follow all test procedures.
  • You must be between 18 and 65 years old.
  • You should not have other sleep disorders like sleep apnea or narcolepsy.
  • Your doctor must confirm it's safe for you to join the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06590662Not yet recruiting· Phase 2
Solriamfetol for idiopathic hypersomnia

This trial tests a medication, solriamfetol, to see if it helps people with idiopathic hypersomnia stay awake during the day. It may be an option if you have trouble staying awake despite getting enough sleep at night.

Montpellier
NCT06568367Recruiting· Phase 3
Solriamfetol for shift work disorder (SUSTAIN trial)

This study tests a medication called Solriamfetol (Sunosi) to see if it helps people with shift work disorder stay awake and alert during their shifts. It is a Phase 3 trial, which means it is being studied in a larger group to confirm how well it works and check for side effects.

Auburn, Alabama
NCT06170970Recruiting· Phase 2
Solriamfetol for fatigue in multiple sclerosis

This study tests whether solriamfetol, a medication that promotes wakefulness, can reduce fatigue in people with multiple sclerosis. If you struggle with tiredness and sleepiness, this trial may help you understand how this drug works for MS-related fatigue.

Baltimore, Maryland
NCT07717892Recruiting· Phase 3
Solriamfetol for teens with ADHD

This study tests a new medicine, solriamfetol, to see if it helps teenagers with ADHD. The medicine is taken as a tablet and may improve focus and reduce symptoms.

Dothan, Alabama
NCT07717879Recruiting· Phase 3
Testing solriamfetol for children with ADHD

This trial tests whether a medication called solriamfetol can safely help children with ADHD. If your child is between 6 and 12 years old and has ADHD, this study may be an option.

Dothan, Alabama
NCT06413433Recruiting· Phase 3
Solriamfetol for binge eating disorder

This study tests whether a drug called solriamfetol can help reduce binge eating episodes. It works on brain chemicals involved in mood and appetite control.

Encino, California

Hear when a new Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.